Dr. Narain is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
865 Northern Blvd
Suite 302
Great Neck, NY 11021Phone+1 516-708-2550
Education & Training
New York Presbyterian Hospital (Cornell Campus)Fellowship, Rheumatology, 2012 - 2014
MetroWest Medical CenterResidency, Internal Medicine, 2009 - 2012
Adichunchanagiri Institute of Medical SciencesClass of 1999
Certifications & Licensure
NY State Medical License 2014 - 2026
MA State Medical License 2009 - 2012- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Rheumatology
Clinical Trials
- Study of Anti-Malarials in Incomplete Lupus Erythematosus Start of enrollment: 2017 Dec 28
Roles: Contact
- Platform Clinical Study for Conquering Scleroderma Start of enrollment: 2024 Apr 01
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 1 citationsFactors associated with immune responses to SARS-CoV-2 vaccination in individuals with autoimmune diseases.Erik Anderson, Michael Powell, Emily Yang, Ananya Kar, Tung Ming Leung
JCI Insight. 2024-06-04 - 3 citationsThe differential role of SSa/SSb and Ro52 antibodies in defining clinical phenotypes in idiopathic inflammatory myopathies.Ana Valle, Sonali Narain, Maria-Louise Barilla-Labarca, Galina Marder
Seminars in Arthritis and Rheumatism. 2024-04-01 - 5 citationsBelimumab treatment of adult idiopathic inflammatory myopathy.Galina Marder, Tam Quach, Priyal Chadha, Preeya Nandkumar, Jimmy Tsang
Rheumatology. 2024-03-01
Press Mentions
- Clinical Trials and Research News Weekly Roundup | Treat COVID-19 Patients Early Antiviral Cocktail?November 2nd, 2020
- Feinstein Institutes for Medical Research Breakthrough on How to Treat COVID-19 Cytokine StormOctober 22nd, 2020
- Comparative Survival Analysis of Immunomodulatory Therapy for COVID-19 'Cytokine Storm'October 16th, 2020
Professional Memberships
- Fellows-in-Training 3rd year
Other Languages
- Hindi, Kannada
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
